Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Exp Cell Res ; 319(4): 536-45, 2013 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-23246570

RESUMO

Epidemiological studies report a negative association between circulating bilirubin concentrations and the risk for cancer and cardiovascular disease. Structurally related tetrapyrroles also possess in vitro anti-genotoxic activity and may prevent mutation prior to malignancy. Furthermore, few data suggest that tetrapyrroles exert anti-carcinogenic effects via induction of cell cycle arrest and apoptosis. To further investigate whether tetrapyrroles provoke DNA-damage in human cancer cells, they were tested in the single cell gel electrophoresis assay (SCGE). Eight tetrapyrroles (unconjugated bilirubin, bilirubin ditaurate, biliverdin, biliverdin-/bilirubin dimethyl ester, urobilin, stercobilin and protoporphyrin) were added to cultured Caco2 and HepG2 cells and their effects on comet formation (% tail DNA) were assessed. Flow cytometric assessment (apoptosis/necrosis, cell cycle, intracellular radical species generation) assisted in revealing underlying mechanisms of intracellular action. Cells were incubated with tetrapyrroles at concentrations of 0.5, 5 and 17µM for 24h. Addition of 300µM tertiary-butyl hydroperoxide to cells served as a positive control. Tetrapyrrole incubation mostly resulted in increased DNA-damage (comet formation) in Caco2 and HepG2 cells. Tetrapyrroles that are concentrated within the intestine, including protoporphyrin, urobilin and stercobilin, led to significant comet formation in both cell lines, implicating the compounds in inducing DNA-damage and apoptosis in cancer cells found within organs of the digestive system.


Assuntos
Dano ao DNA/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Neoplasias/patologia , Tetrapirróis/metabolismo , Tetrapirróis/farmacologia , Antioxidantes/farmacologia , Pigmentos Biliares/farmacologia , Bilirrubina/análogos & derivados , Bilirrubina/farmacologia , Células CACO-2 , Ensaio Cometa , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Citometria de Fluxo , Células Hep G2 , Humanos , Neoplasias/genética , Concentração Osmolar , Protoporfirinas/farmacologia , Urobilina/farmacologia
2.
Mutat Res ; 658(1-2): 28-41, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-17602853

RESUMO

Bile pigments, including bilirubin and biliverdin, are endogenous compounds belonging to the porphyrin family of molecules. In the past, bile pigments and bilirubin in particular were thought of as useless by-products of heme catabolism that can be toxic if they accumulate. However, in the past 20 years, research probing the physiological relevance of bile pigments has been mounting, with evidence to suggest bile pigments possess significant antioxidant and anti-mutagenic properties. More specifically, bile pigments are potent peroxyl radical scavengers and inhibit the mutagenic effects of a number of classes of mutagens (polycyclic aromatic hydrocarbons, heterocyclic amines, oxidants). Coincidentally, persons with elevated circulating bilirubin concentrations have a reduced prevalence of cancer and cardio-vascular disease. Despite the encouraging in vitro anti-mutagenic effects of bile pigments, relatively little research has been conducted on their inhibitory capacity in bacterial and cultured cell assays of mutation, which might link the existing in vitro and in vivo observations. This is the first review to summarise the published data and it is our hope it will stimulate further research on these potentially preventative compounds.


Assuntos
Antimutagênicos/metabolismo , Pigmentos Biliares/metabolismo , Sequestradores de Radicais Livres/metabolismo , Animais , Antimutagênicos/química , Antimutagênicos/farmacologia , Pigmentos Biliares/química , Pigmentos Biliares/farmacologia , Biliverdina/química , Biliverdina/metabolismo , Biliverdina/farmacologia , Proliferação de Células/efeitos dos fármacos , Sequestradores de Radicais Livres/química , Sequestradores de Radicais Livres/farmacologia , Humanos , Estrutura Molecular , Oxidantes/antagonistas & inibidores , Oxidantes/metabolismo
3.
Free Radic Res ; 31(6): 631-40, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10630686

RESUMO

In the present in vitro and in vivo study we investigated the pro-oxidant effects of hemoglobin, as well as the antioxidant effects of its metabolites, in the brain. Incubation of rat brain homogenates with hemoglobin (0-10 microM) but not hemin induced lipid peroxidation up to 24 h (EC50 = 1.2 microM). Hemoglobin's effects were similar to ferrous ion (EC50 = 1.7 microM) and were blocked by the chelating agent deferoxamine (IC50 0.5 microM) and a nitric oxide-releasing compound S-nitrosoglutathione (IC50 = 40 microM). However, metabolites of hemoglobin - biliverdin and bilirubin - inhibited brain lipid peroxidation induced by cell disruption and hemoglobin (biliverdin IC50 = 12-30 and bilirubin IC50 = 75-170 microM). Biliverdin's antioxidative effects in spontaneous and iron-evoked lipid peroxidation were further augmented by manganese (2 microM) since manganese is an antioxidative transition metal and conjugates with bile pigments. Intrastriatal infusion of hemoglobin (0-24 nmol) produced slight, but significant 20-22% decreases in striatal dopamine levels. Whereas, intrastriatal infusion of ferrous citrate (0-24 nmol) dose-dependently induced a greater 66% depletion of striatal dopamine which was preceded by an acute increase of lipid peroxidation. In conclusion, contrary to the in vitro results hemoglobin is far less neurotoxic than ferrous ions in the brain. It is speculated that hemoglobin may be partially detoxified by heme oxygenase and biliverdin reductase to its antioxidative metabolites in the brain. However, in head trauma and stroke, massive bleeding could significantly produce iron-mediated oxidative stress and neurodegeneration which could be minimized by endogenous antioxidants such as biliverdin, bilirubin, manganese and S-nitrosoglutathione.


Assuntos
Pigmentos Biliares/metabolismo , Encéfalo/metabolismo , Glutationa/análogos & derivados , Hemoglobinas/metabolismo , Ferro/metabolismo , Manganês/metabolismo , Compostos Nitrosos/metabolismo , Estresse Oxidativo/fisiologia , Animais , Antioxidantes/metabolismo , Pigmentos Biliares/farmacologia , Bilirrubina/metabolismo , Bilirrubina/farmacologia , Biliverdina/metabolismo , Biliverdina/farmacologia , Encéfalo/citologia , Encéfalo/efeitos dos fármacos , Ácido Cítrico , Desferroxamina/farmacologia , Compostos Ferrosos/farmacologia , Glutationa/metabolismo , Glutationa/farmacologia , Hemoglobinas/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Manganês/farmacologia , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Compostos Nitrosos/farmacologia , Oxidantes/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , S-Nitrosoglutationa , Extratos de Tecidos/metabolismo
4.
Biochem J ; 320 ( Pt 2): 681-6, 1996 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-8973584

RESUMO

Using recently developed molecular-shape description algorithms, we searched the Available Chemical Directory for known compounds similar in shape to the potent HIV-1 protease inhibitor Merck L-700,417; 15 compounds most similar in shape to the inhibitor were selected for testing in vitro. Four of these inhibited the protease at 100 microM or less and the most active of the four were the naturally occurring pigments biliverdin and bilirubin. Biliverdin and bilirubin inhibited recombinant HIV-1 protease in vitro at pH 7.8 with K1 values of approx. 1 microM, and also inhibited HIV-2 and simian immunodeficiency virus proteases. The related pyrrolic pigments stercobilin, urobilin, biliverdin dimethyl ester and xanthobilirubic acid showed similar inhibitory activity at low micromolar concentrations. Biliverdin, bilirubin and xanthobilirubic acid did not inhibit viral polyprotein processing in cultured cells, but they reduced viral infectivity significantly. At 100 microM, xanthobilirubic acid affected viral assembly, resulting in a 50% decrease in the generation of infectious particles. In contrast, at the same concentrations biliverdin and bilirubin exerted little or no effect on viral assembly but blocked infection of HeLaT4 cells by 50%. These results suggest that bile pigments might be a new class of potential lead compounds for developing protease inhibitors and they raise the question of whether hyperbilirubinaemia can influence the course of HIV infection.


Assuntos
Pigmentos Biliares/farmacologia , Inibidores da Protease de HIV/farmacologia , Protease de HIV/metabolismo , HIV-1/fisiologia , Ácido Aspártico Endopeptidases/metabolismo , Bilirrubina/análogos & derivados , Bilirrubina/farmacologia , Biliverdina/farmacologia , Linhagem Celular , Dipeptídeos/farmacologia , HIV-1/efeitos dos fármacos , HIV-1/enzimologia , HIV-2/enzimologia , Humanos , Rim , Cinética , Inibidores de Proteases/farmacologia , Proteínas Recombinantes/antagonistas & inibidores , Vírus da Imunodeficiência Símia/enzimologia , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA